Simplex Trading’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $147K | Buy |
+2,850
| New | +$145K | ﹤0.01% | 4651 |
|
|
2025
Q4 | – | Sell |
-1,981
| Closed | -$94K | – | 10010 |
|
|
2025
Q3 | $94K | Buy |
+1,981
| New | +$79.8K | ﹤0.01% | 5824 |
|
|
2025
Q2 | – | Sell |
-177
| Closed | -$5.67K | – | 9702 |
|
|
2025
Q1 | $5K | Buy |
177
+27
| +18% | +$957 | ﹤0.01% | 7605 |
|
|
2024
Q4 | $5K | Buy |
+150
| New | +$5.28K | ﹤0.01% | 7662 |
|
|
2024
Q1 | – | Sell |
-2,482
| Closed | -$73.9K | – | 9859 |
|
|
2023
Q4 | $71K | Buy |
2,482
+2,342
| +1,673% | +$62.1K | ﹤0.01% | 5739 |
|
|
2023
Q3 | $3K | Buy |
+140
| New | +$4.26K | ﹤0.01% | 7957 |
|
|
2022
Q1 | – | Sell |
-417
| Closed | -$12.8K | – | 11367 |
|
|
2021
Q4 | $12K | Sell |
417
-6,454
| -94% | -$196K | ﹤0.01% | 8883 |
|
|
2021
Q3 | $215K | Sell |
6,871
-610
| -8% | -$16.4K | ﹤0.01% | 5481 |
|
|
2021
Q2 | $230K | Sell |
7,481
-174
| -2% | -$5.33K | ﹤0.01% | 5461 |
|
|
2021
Q1 | $0 | Buy |
+7,655
| New | +$214K | ﹤0.01% | 9983 |
|
|
2020
Q4 | – | Sell |
-1,843
| Closed | -$39.7K | – | 9062 |
|
|
2020
Q3 | $38K | Sell |
1,843
-19,932
| -92% | -$452K | ﹤0.01% | 5879 |
|
|
2020
Q2 | $517K | Sell |
21,775
-10,650
| -33% | -$235K | ﹤0.01% | 2865 |
|
|
2020
Q1 | $583K | Sell |
32,425
-7,263
| -18% | -$153K | ﹤0.01% | 2433 |
|
|
2019
Q4 | $941K | Buy |
39,688
+19,143
| +93% | +$465K | ﹤0.01% | 2143 |
|
|
2019
Q3 | $564K | Buy |
20,545
+13,679
| +199% | +$405K | ﹤0.01% | 2500 |
|
|
2019
Q2 | $227K | Buy |
+6,866
| New | +$235K | ﹤0.01% | 3334 |
|
|
2019
Q1 | – | Sell |
-24,583
| Closed | -$915K | – | 7812 |
|
|
2018
Q4 | $816K | Buy |
24,583
+19,577
| +391% | +$842K | ﹤0.01% | 1799 |
|
|
2018
Q3 | $252K | Sell |
5,006
-106
| -2% | -$5.24K | ﹤0.01% | 3384 |
|
|
2018
Q2 | $305K | Buy |
5,112
+1,638
| +47% | +$84.9K | ﹤0.01% | 2999 |
|
|
2018
Q1 | $159K | Sell |
3,474
-2,777
| -44% | -$116K | 0.01% | 1416 |
|
|
2017
Q4 | $249K | Sell |
6,251
-1,889
| -23% | -$74.6K | 0.01% | 1125 |
|
|
2017
Q3 | $325K | Sell |
8,140
-12,674
| -61% | -$548K | 0.01% | 911 |
|
|
2017
Q2 | $897K | Sell |
20,814
-6,633
| -24% | -$236K | 0.04% | 406 |
|
|
2017
Q1 | $859K | Buy |
+27,447
| New | +$736K | 0.04% | 438 |
|
|
2016
Q3 | – | Sell |
-1,472
| Closed | -$33.3K | – | 6433 |
|
|
2016
Q2 | $29K | Buy |
+1,472
| New | +$26.1K | ﹤0.01% | 2562 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
Simplex Trading's SUPN Position: Q1 2026 in Review
Simplex Trading opened a new position in Supernus Pharmaceuticals (SUPN) in Q1 2026: 2,850 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #4651 among its holdings. This is a return to the name: Simplex Trading previously reported a position in SUPN as recently as Q3 2025.
Simplex Trading first reported a position in SUPN in Q2 2016 and has held it in 25 quarters since. The position peaked at $941K in Q4 2019. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.
- Simplex Trading held 2,850 shares of Supernus Pharmaceuticals worth $147K as of Q1 2026.
- Supernus Pharmaceuticals was a new Simplex Trading position in Q1 2026.
- Supernus Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4651 holding.
- Simplex Trading first reported a position in Supernus Pharmaceuticals in Q2 2016 and has held it in 25 quarters since.
- Simplex Trading's Supernus Pharmaceuticals position peaked at $941K in Q4 2019.
- 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.